&nbsp;

Discharge-Letter-Template-Colposcopist-To-Primary-Care-Screening-Cessation-FR.docx

Jan 2025

Document

Discharge-Letter-Template-Colposcopist-To-Patient-FR.docx

Jan 2025

Document

Discharge-Letter-Template-Colposcopist-To-Patient-Hysterectomy-FR.docx

Jan 2025

Document

Discharge-Letter-Template-Colposcopist-To-Patient-Screening-Cessation-FR.docx

Jan 2025

Regimen

DURV

Cancer Type:

Lung,

Small Cell

Intent: Adjuvant

Drugs Used:

durvalumab (Compassionate)

Quick Link(s):

Regimen Monograph

Apr 2025

Regimen

DEXAPOMASELI

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

dexamethasone,

pomalidomide (Unfunded),

selinexor (Unfunded)

Quick Link(s):

Regimen Monograph

May 2025

Regimen

DOXOTRBC

Cancer Type:

Sarcoma,

Soft Tissue

Intent: Palliative

Drugs Used:

DOXOrubicin,

trabectedin (Unfunded)

Quick Link(s):

Regimen Monograph

May 2025

Regimen

NIVL+IPIL

Cancer Type:

Skin,

Melanoma

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab,

ipilimumab

Quick Link(s):

Regimen Monograph

May 2025

Regimen

NIVL

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

May 2025

Drug

niraparib / abiraterone

Other Name(s): Akeega™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Sep 2025

Document

DPMOropharyngealSquamousDiagnosis.pdf

Jun 2025

Document